David Margolin

David Margolin

Company: uniQure

Job title: Vice President - Clinical Development


Determining Appropriate Clinical Endpoints for CNS Gene Therapies to Treat Neurodegenerative Disorders 9:00 am

Successfully detecting significant changes in a slow-progressing disease within the timeframe of a clinical trial Utilizing a dual endpoint strategy to combine surrogate and clinical endpoints to gain a comprehensive picture of the gene therapies impact in the CNS Discussing novel techniques to analyze patients and define specific patient subgroups, disease statusRead more

day: Day Two Whole

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.